BACKGROUND: Torquetenovirus (TTV) viremia is emerging asa promising tool to assess functional immune competence, to predict posttransplant immune-related complications, and eventually to customize immunosuppression.METHODS: In this study, 327 blood samples were tested using two real-time PCR (rtPCR) assays both targeted to the untranslated region of the TTV genome. The first assay was an in-house rtPCR developed by our group, the second one was the recently marketed TTV R-GENE assay.RESULTS: In the validation study, the TTV R-GENE showed good performances in precision and reproducibility, and sensitivity as low as 12 TTV DNA copies/mL, like previously reported for the in-house rtPCR. The Bland-Altman analysis showed that the mean difference between the two methods was -0.3 log copies/mL. In the comparison study, 69% and 72% of samples were detected positive by rtPCR and TTV R-GENE, respectively (94% concordance, kappa=0.88). Performances did not differ between the two rtPCRs by type of TTV group examined. When a newly-developed in-house digital droplet PCR was applied for TTV quantification and used as an alternative method of comparison on 94 samples, the results strongly correlated with those obtained by the two rtPCR methods (99% concordance).CONCLUSION: In summary, all the molecular methods assayed are highly sensitive and accurate in quantitation of TTV DNA in blood samples.

Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence / Macera, Lisa; Giorgio Spezia, Pietro; Medici, Chiara; Rofi, Eleonora; Del Re, Marzia; Focosi, Daniele; Mazzetti, Paola; Navarro, David; Antonelli, Guido; Danesi, Romano; Pistello, Mauro; Maggi, Fabrizio. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2019). [10.1002/jmv.25488]

Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence

Guido Antonelli;
2019

Abstract

BACKGROUND: Torquetenovirus (TTV) viremia is emerging asa promising tool to assess functional immune competence, to predict posttransplant immune-related complications, and eventually to customize immunosuppression.METHODS: In this study, 327 blood samples were tested using two real-time PCR (rtPCR) assays both targeted to the untranslated region of the TTV genome. The first assay was an in-house rtPCR developed by our group, the second one was the recently marketed TTV R-GENE assay.RESULTS: In the validation study, the TTV R-GENE showed good performances in precision and reproducibility, and sensitivity as low as 12 TTV DNA copies/mL, like previously reported for the in-house rtPCR. The Bland-Altman analysis showed that the mean difference between the two methods was -0.3 log copies/mL. In the comparison study, 69% and 72% of samples were detected positive by rtPCR and TTV R-GENE, respectively (94% concordance, kappa=0.88). Performances did not differ between the two rtPCRs by type of TTV group examined. When a newly-developed in-house digital droplet PCR was applied for TTV quantification and used as an alternative method of comparison on 94 samples, the results strongly correlated with those obtained by the two rtPCR methods (99% concordance).CONCLUSION: In summary, all the molecular methods assayed are highly sensitive and accurate in quantitation of TTV DNA in blood samples.
2019
digital droplet PCR; methods comparison; real-time PCR; torquetenovirus
01 Pubblicazione su rivista::01a Articolo in rivista
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence / Macera, Lisa; Giorgio Spezia, Pietro; Medici, Chiara; Rofi, Eleonora; Del Re, Marzia; Focosi, Daniele; Mazzetti, Paola; Navarro, David; Antonelli, Guido; Danesi, Romano; Pistello, Mauro; Maggi, Fabrizio. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2019). [10.1002/jmv.25488]
File allegati a questo prodotto
File Dimensione Formato  
Macera_Comparative_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 912.87 kB
Formato Adobe PDF
912.87 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1524531
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 15
social impact